Emergents ́ approach is to achieve balance
in the products that we develop through a pipeline
comprising innovative vaccines and therapeutics
that target diseases worldwide.
 

Emergent Pipeline

 

 

Biodefense Products

 

Product Candidate

Disease

Stage

[Anthrax Immune Globulin Intravenous (Human)]

Anthrax 

Phase 3

(Recombinant Protective Antigen Anthrax Vaccine, Purified)

Anthrax 

Phase 2

(Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant)

Anthrax 

Phase 2

(Fully Human Anthrax Monoclonal Antibody)

Anthrax 

Phase 1

 

Commercial Products

 

Product Candidate

Disease

Stage

Chronic Lymphocytic Leukemia (CLL)

Phase 2